MINK1

MINK1 (MAP4K6) is a germinal center kinase-family serine/threonine kinase that functions as an upstream activator of JNK and other MAPK cascades across multiple cell types, coupling diverse extracellular signals to cell fate decisions, immune regulation, and cytoskeletal remodeling. In neurons, MINK1 activates DLK/JNK signaling to promote axonal degeneration and selectively binds GTP-loaded Rap2 to antagonize Rap2-driven removal of surface AMPA receptors at postsynapses; it also phosphorylates Prickle to direct Rab5-dependent endosomal trafficking required for Wnt/planar cell polarity signaling (PMID:28993483, PMID:21048137, PMID:22037766). MINK1 directly phosphorylates SMAD2 at T324 to suppress TGFβ-SMAD2 signaling and Th17 differentiation, phosphorylates NLRP3 at S725 to prime inflammasome assembly in macrophages, and mediates TCR-coupled JNK/Bim-dependent negative selection in thymocytes (PMID:28400474, PMID:34480147, PMID:15608642). As a subunit of the STRIPAK complex, MINK1 interacts with STRN4/PP2A, which negatively regulates its kinase activity, and is required for cytokinesis abscission; it is additionally essential for platelet activation and thrombus formation through ERK/p38/Akt pathways (PMID:22665485, PMID:26598717).

1. 2002 Medium

   Establishing the genomic identity of MINK1 revealed that it overlaps the CHRNE locus in an antiparallel configuration, a structural feature arising from polyadenylation-signal mutations in early hominoids, thereby anchoring the gene's chromosomal context.

   Evidence Comparative genomic sequence analysis across primates and placental mammals

   PMID:12087176

   Open questions at the time

   • No functional consequence of the overlap on MINK1 expression or regulation was tested
   • Analysis limited to locus structure without protein-level experiments
2. 2004 High

   Loss-of-function studies first placed MINK1 within a specific immunological signaling pathway, showing it is selectively required for TCR-mediated negative selection of thymocytes through JNK activation and Bim upregulation, but dispensable for positive selection.

   Evidence Genetic loss-of-function in thymocytes with JNK activity and Bim expression analysis

   PMID:15608642

   Open questions at the time

   • Direct kinase substrates mediating JNK activation were not identified
   • Mechanism distinguishing negative from positive selection pathways remained unclear
3. 2008 Medium

   Biochemical identification of MINK1 as a specific effector of GTP-bound Rap2 (requiring Rap2 Phe39) established its selectivity within the Ras superfamily and connected it to postsynaptic scaffold phosphorylation via TANC1.

   Evidence Affinity chromatography/mass spectrometry, yeast two-hybrid, co-immunoprecipitation, in-cell phosphorylation assays

   PMID:18930710

   Open questions at the time

   • TANC1 phosphorylation site not mapped
   • In vitro reconstitution of TANC1 phosphorylation was limited
4. 2010 High

   Functional studies in neurons demonstrated that MINK1 binding to activated Rap2 antagonizes Rap2-driven AMPA receptor internalization and is required for normal dendritic arborization, establishing MINK1 as a synaptic signaling regulator.

   Evidence Co-immunoprecipitation, dominant-negative overexpression, live-cell imaging, surface AMPA receptor quantification in cultured neurons

   PMID:21048137

   Open questions at the time

   • The kinase activity of MINK1 versus scaffolding in Rap2 antagonism was not dissected
   • In vivo relevance to synaptic plasticity not tested
5. 2011 High

   Discovery that MINK1 phosphorylates Prickle on a conserved threonine to control Rab5-dependent endosomal trafficking extended its role to Wnt/planar cell polarity signaling, validated genetically in both Drosophila and Xenopus.

   Evidence In vitro kinase assay, mass spectrometry, Drosophila genetic interaction, Xenopus convergent extension assay, endosomal trafficking assays

   PMID:22037766

   Open questions at the time

   • Mammalian PCP phenotype not examined
   • How MINK1 itself is recruited to Prickle-containing endosomes was not resolved
6. 2012 High

   Identification of MINK1 as a STRIPAK complex subunit, regulated by STRN4/PP2A-mediated dephosphorylation, revealed a new layer of kinase activity control and demonstrated that MINK1 is essential for cytokinesis abscission.

   Evidence Mass spectrometry, co-immunoprecipitation, siRNA knockdown with time-lapse microscopy, in vitro kinase activity assay

   PMID:22665485

   Open questions at the time

   • Direct cytokinesis substrates of MINK1 were not identified
   • Relationship between STRIPAK-regulated MINK1 and its other signaling roles was not explored
7. 2015 High

   In vivo knockout studies established that MINK1 is essential for platelet activation, aggregation, and thrombus formation, linking its kinase activity to ERK, p38, and Akt pathways in hemostasis.

   Evidence MINK1 knockout mice, tail-bleeding assay, ferric chloride thrombosis model, platelet functional assays, signaling pathway analysis

   PMID:26598717

   Open questions at the time

   • Direct platelet substrates of MINK1 were not identified
   • Mechanism connecting MINK1 to ADP secretion was not resolved
8. 2017 High

   Two studies expanded MINK1's roles in immunity and neurodegeneration: direct phosphorylation of SMAD2 at T324 was shown to suppress Th17 differentiation (validated in EAE), while pharmacological and genetic inhibition placed MINK1 upstream of DLK stabilization and JNK retrograde signaling in axonal degeneration.

   Evidence In vitro kinase assay with SMAD2 substrate and T324 mutagenesis, MINK1 KO mice in EAE model; siRNA knockdown and pharmacological inhibition in mouse DRG neurons with immunofluorescence

   PMID:28400474 PMID:28993483

   Open questions at the time

   • Whether MINK1 directly phosphorylates DLK or acts through an intermediary was not resolved
   • ROS-dependent activation mechanism of MINK1 kinase activity was not structurally characterized
9. 2019 Medium

   Extension of the SMAD2-inhibitory role to cartilage biology showed that MINK1 deficiency protects against age-related osteoarthritis by enhancing SMAD2 activation in chondrocytes, while paradoxically accelerating injury-induced OA through enhanced subchondral bone osteogenesis.

   Evidence Mink1 KO mice in DMM and aging OA models, histology, SMAD2 phosphorylation assay with MINK1 overexpression

   PMID:31647983

   Open questions at the time

   • Direct SMAD2 phosphosite involvement in chondrocytes was not confirmed by mutagenesis
   • Mechanism of osteogenesis enhancement by MINK1 loss was not dissected
10. 2021 High

    Identification of NLRP3 S725 as a direct MINK1 phosphosite essential for inflammasome priming established MINK1 as a key innate immune kinase, with ROS serving as an upstream activator of MINK1 in macrophages.

    Evidence In vitro kinase assay, NLRP3 S725 mutagenesis, co-immunoprecipitation, MINK1 KO mice in sepsis and peritonitis models

    PMID:34480147

    Open questions at the time

    • Whether MINK1-mediated NLRP3 phosphorylation is sufficient without additional priming signals was not tested
    • Structural basis for MINK1–NLRP3 LRR domain interaction was not determined
11. 2022 Medium

    A kinome-wide CRISPR screen linked MINK1 to chemoresistance by showing it promotes AKT S473 phosphorylation, enabling MDM2-mediated p53 degradation and 5FU resistance in oral squamous cell carcinoma.

    Evidence CRISPR/Cas9 kinome KO screen, phosphorylation array, xenograft mouse and zebrafish models

    PMID:36182968

    Open questions at the time

    • Whether MINK1 directly phosphorylates AKT or acts through an intermediary kinase was not determined
    • Generalizability to other cancer types not established

• Key unresolved questions include the structural basis for MINK1 substrate selectivity across its diverse substrates, how STRIPAK-mediated regulation of MINK1 intersects with its immune and neuronal functions, and the identity of direct substrates in platelets and cytokinesis.
• No crystal or cryo-EM structure of MINK1 kinase domain with a substrate
• Integration of STRIPAK regulation with tissue-specific signaling outputs is unexplored
• Direct platelet and cytokinesis substrates remain unidentified